Fukuoka, Japan

Mitsuyoshi Yasumoto

This inventor holds 3 USPTO granted patents. Top assignee: Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1988-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mitsuyoshi Yasumoto. Retrieved from https://idiyas.com/inventor/mitsuyoshi-yasumoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 1988-1990

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mitsuyoshi Yasumoto: Innovator in Pharmaceutical Chemistry

Introduction

Mitsuyoshi Yasumoto is a prominent inventor based in Fukuoka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzoxazine compounds and purine derivatives. With a total of 3 patents to his name, Yasumoto continues to push the boundaries of medical science.

Latest Patents

Yasumoto's latest patents include groundbreaking research on benzoxazine compounds. These compounds exhibit 5-HT₃ receptor antagonistic activity, making them useful as antiemetics and in various pharmaceutical applications. His work on purine derivatives further enhances the potential for new therapeutic compositions in the medical field.

Career Highlights

Yasumoto is affiliated with Yoshitomi Pharmaceutical Industries, Ltd., where he has been instrumental in advancing research and development. His expertise in pharmaceutical chemistry has led to innovative solutions that address critical health issues.

Collaborations

Throughout his career, Yasumoto has collaborated with notable colleagues, including Takeshi Kawakita and Mitsuharu Sano. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research.

Conclusion

Mitsuyoshi Yasumoto's contributions to pharmaceutical chemistry exemplify the impact of innovation in healthcare. His work continues to pave the way for new treatments and therapies that can improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…